The Peter Doherty Institute for Infection and Immunity
The Doherty Institute is a world-class institute combining research, teaching, public health and reference laboratory services, diagnostic services and clinical care into infectious diseases and immunity.
The establishment of the Doherty Institute represents a radical change in the capacity of Australia and the world to detect, investigate and respond to existing, emerging and re-emerging infectious diseases and agents, with a major focus on diseases that pose serious public and global health threats such as influenza, tuberculosis, HIV, viral hepatitis and drug resistant bacteria. The Doherty’s activities are multi-disciplinary and cross-sectoral, placing great emphasis on translational research and improving clinical outcomes. Teams of interdisciplinary scientists, clinicians and epidemiologists collaborate on a wide spectrum of activities - from basic immunology and discovery research, to the development of new vaccines and new preventative and treatment methods, to surveillance and investigation of disease outbreaks.
Sacha Pidot, The Peter Doherty Institute for Infection and Immunity
Scientists are racing to discover new antibiotics that can defeat these drug-resistant superbugs. So how is the newly developed antibiotic clovibactin different?
Adam Wheatley, The University of Melbourne and Jennifer Juno, The Peter Doherty Institute for Infection and Immunity
Firstly, there is no such thing as ‘too much’ immunity. Beyond the regular side-effects of a vaccine, there are no known additional risks to being re-vaccinated soon after an infection.
Ash Porter, The Peter Doherty Institute for Infection and Immunity and Michelle Wille, The University of Melbourne
La grippe aviaire connaît une épidémie d’un niveau inédit, et des victimes humaines ont été confirmées. Quand une maladie animale peut-elle frapper notre espèce ? Quels sont les risques ?
Ash Porter, The Peter Doherty Institute for Infection and Immunity and Michelle Wille, University of Sydney
Virus yang menyebabkan flu burung adalah spesies yang sama yang menyebabkan influenza pada manusia musiman, flu babi, flu kuda, dan flu anjing, walaupun subtipe dan strain yang berbeda terlibat.
Analysis of Victoria’s winter COVID wave found Paxlovid and Lagevrio reduced the risk of hospitalisation and death. The results were better for Paxlovid, but not everyone can take it.
Authorities have been warned about five virus families that could cause future pandemics. Here are snapshots of the diseases each can cause and why we should be worried.
Kylie Quinn, RMIT University and Jennifer Juno, The Peter Doherty Institute for Infection and Immunity
The infection of a Victorian aged-worker who had received their first COVID vaccine dose isn’t completely surprising. We need two doses for optimal protection.
Director, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and Royal Melbourne Hospital and Consultant Physician, Department of Infectious Diseases, Alfred Hospital and Monash University, The Peter Doherty Institute for Infection and Immunity